Thermo Fisher has completed the expansion of one of its manufacturing facilities in New York, taking another step forward in its broader investment plan for sites in the US and globally.
The $76 million expansion of its dry powder media manufacturing facility in Grand Island, New York, just north of Buffalo, will allow more capacity to support Thermo Fisher’s global supply and extend its capabilities for materials used in vaccines and biologic therapy development and manufacturing.
The Grand Island expansion was announced earlier last year as part of the company’s $650 million investment into several infrastructure projects to increase its bioprocessing production. That investment includes site expansions across the US, UK, Singapore and China.
“Our expanded Grand Island site represents a significant milestone in our investment to double our total manufacturing capacity by the end of 2023. With the harmonized capabilities of our global manufacturing sites that enable us to…
Click here to view original post